SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pseudo Biologist who wrote (1395)12/6/1997 1:41:00 PM
From: I. Luttichuys  Read Replies (1) of 1762
 
Hello PB, This is something I just don't have any time to find out. I'm so burdened with studying around here, it's crazy. I somewhat resent the fact I cannot keep up with the science behind some of my picks under these circumstances.
I assume (and it is just an assumption) that the new MAbs are not different as to target. The options would be CD19 or CD10 if I recall but, somehow I think I would have heard if something so fundamental as a change in this area were contemplated.
It certainly would be very helpful to know the mechanism behind this new Ab. That would afford some insight into risk as you point out.
Would a call to investor relations be in order?
RE: GSTRF... yes, still a bull and holding my position until 2003 as it was suggested I do. I expect another split in the January time frame.
I don't know if you heard me mention it but, I have been accumulating SVM as well for a few months. As an LP, many funds and pensions cannot buy it. January 1st, it reverts to corporate status. I have heard some good things about the institutional demand which may appear for this stock at that time. Looks like some people have been jumping the gun the last few sessions. Anyway... worth a look.
BENNETT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext